🇺🇸 FDA
Patent

US 10604493

Compositions, methods of use, and methods of treatment

granted A61KA61K31/41A61K31/416

Quick answer

US patent 10604493 (Compositions, methods of use, and methods of treatment) held by The Regents of the University of California expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/41, A61K31/416, A61K31/4184, A61K45/06